General Pharmacology — MCQs

General Pharmacology Indian Medical PG Practice Questions and MCQs

Question 401: Which of the following is NOT used in erectile dysfunction?

A. PGE-2
B. Vardenafil
C. Phenylephrine (Correct Answer)
D. Alprostadil

Explanation: **Explanation:** The management of erectile dysfunction (ED) involves enhancing vasodilation and blood flow to the corpora cavernosa. **Phenylephrine** is the correct answer because it is a selective **alpha-1 (α1) agonist**, which causes potent vasoconstriction. In the context of male reproductive health, phenylephrine is actually the drug of choice for treating **priapism** (a prolonged, painful erection) by inducing detumescence through smooth muscle contraction. **Analysis of Options:** * **Vardenafil (Option B):** A selective **PDE-5 inhibitor** (like Sildenafil). It prevents the breakdown of cGMP, leading to smooth muscle relaxation and increased blood flow, making it a first-line oral treatment for ED. * **Alprostadil (Option D):** This is a synthetic **Prostaglandin E1 (PGE1)** analogue. It increases cAMP levels to cause vasodilation. It is administered via intracavernosal injection or intraurethral pellets for ED. * **PGE-2 (Option A):** While PGE1 (Alprostadil) is more commonly used, Prostaglandin E2 also possesses vasodilatory properties and has been utilized in various formulations for ED, though it is less common than PGE1. **High-Yield Clinical Pearls for NEET-PG:** 1. **Priapism Treatment:** Phenylephrine is preferred over adrenaline for priapism because it lacks β-activity, minimizing the risk of cardiac arrhythmias. 2. **PDE-5 Inhibitor Contraindication:** Never co-administer nitrates with PDE-5 inhibitors (e.g., Vardenafil) as it can lead to life-threatening hypotension. 3. **Alprostadil:** It is the drug of choice for maintaining a **Patent Ductus Arteriosus (PDA)** in neonates with cyanotic heart disease.

Question 402: What is a prodrug?

A. An inactive substance that is converted into an active drug within the body. (Correct Answer)
B. An active drug that is converted into an inactive metabolite within the body.
C. The measure of the amount of drug necessary to produce an effect of a given magnitude.
D. A substance that binds to a receptor and elicits a biologic response.

Explanation: **Explanation:** A **prodrug** is a pharmacologically inactive compound that must undergo chemical or enzymatic transformation (usually in the liver) to be converted into its active, therapeutic form. This strategy is often used to improve a drug's bioavailability, reduce toxicity, or ensure site-specific delivery. **Analysis of Options:** * **Option A (Correct):** This defines a prodrug. By administering an inactive form, clinicians can overcome barriers like poor gastric absorption or rapid first-pass metabolism. * **Option B (Incorrect):** This describes the standard process of **drug metabolism or detoxification**, where an active drug is biotransformed into an inactive metabolite for excretion. * **Option C (Incorrect):** This is the definition of **Potency**. Potency refers to the concentration ($EC_{50}$) or dose ($ED_{50}$) of a drug required to produce 50% of its maximum effect. * **Option D (Incorrect):** This defines an **Agonist**. An agonist possesses both affinity (binding) and intrinsic activity (response). **High-Yield NEET-PG Clinical Pearls:** * **Common Prodrugs:** Levodopa (converted to Dopamine), Enalapril (to Enalaprilat), Cyclophosphamide (to Phosphoramide mustard), and Clopidogrel. * **The "Active" Exception:** Most ACE inhibitors are prodrugs, **except Lisinopril and Captopril**. * **Site of Conversion:** Most prodrugs are activated in the liver; however, some are activated at the target site (e.g., Omeprazole in the acidic environment of the parietal cell). * **Clinical Significance:** Patients with severe liver disease may show a poor therapeutic response to prodrugs because they cannot efficiently convert them to their active forms.

Question 403: Which of the following drugs can result in the teratogenic effect shown in the diagram if given during pregnancy?

A. Niacin
B. Retinoic acid (Correct Answer)
C. Thiamine
D. Folic acid

Explanation: **Explanation:** **Retinoic Acid (Vitamin A derivative)** is a potent teratogen. When administered during the first trimester of pregnancy, it interferes with the migration and differentiation of **cranial neural crest cells**. This leads to a specific pattern of malformations known as **Retinoic Acid Embryopathy**, which typically includes craniofacial abnormalities (microtia/anotia, cleft palate), cardiovascular defects (transposition of great vessels), and CNS anomalies (hydrocephalus). Due to its high lipid solubility and long half-life, it is strictly contraindicated in pregnancy (FDA Category X). **Incorrect Options:** * **Niacin (Vitamin B3):** Deficiency causes Pellagra (Dermatitis, Diarrhea, Dementia, Death), but it is not associated with the structural teratogenicity seen with retinoids. * **Thiamine (Vitamin B1):** Deficiency leads to Beriberi or Wernicke-Korsakoff syndrome. It is essential for carbohydrate metabolism and is safe during pregnancy. * **Folic Acid (Vitamin B9):** Unlike retinoids, folic acid is **protective**. Supplementation is mandatory periconceptionally to prevent **Neural Tube Defects (NTDs)** like spina bifida. **High-Yield Clinical Pearls for NEET-PG:** * **Isotretinoin Rule:** Female patients must use two forms of contraception and have two negative pregnancy tests before starting therapy (iPLEDGE program). * **Critical Period:** The most sensitive period for teratogenicity is organogenesis (**weeks 3 to 8** of gestation). * **Other Classic Teratogens:** * **Thalidomide:** Phocomelia (seal-like limbs). * **Valproate:** Neural tube defects (inhibits folate). * **Warfarin:** Fetal Warfarin Syndrome (stippled epiphyses, nasal hypoplasia). * **Phenytoin:** Fetal Hydantoin Syndrome (cleft lip/palate, hypoplastic nails).

Question 404: In pregnancy, all of the following drugs are contraindicated except:

A. ACE Inhibitors
B. Angiotensin Receptor Blockers
C. Propylthiouracil (Correct Answer)
D. Thalidomide

Explanation: **Explanation:** The correct answer is **Propylthiouracil (PTU)**. In pregnancy, managing hyperthyroidism requires balancing maternal health with fetal safety. PTU is the drug of choice during the **first trimester** because it is more highly protein-bound than Methimazole, resulting in less placental transfer and a lower risk of fetal scalp defects (Aplasia cutis) and choanal atresia. **Analysis of Options:** * **Propylthiouracil (PTU):** It is not contraindicated; rather, it is preferred in early pregnancy. While it carries a risk of maternal hepatotoxicity, its limited transplacental passage makes it safer for the embryo during organogenesis. * **ACE Inhibitors (e.g., Enalapril):** These are strictly contraindicated (Category D/X). They interfere with fetal renal development, leading to **oligohydramnios**, renal dysgenesis, hypocalvaria (skull defects), and IUGR. * **Angiotensin Receptor Blockers (ARBs):** Like ACE inhibitors, ARBs are contraindicated as they act on the same Renin-Angiotensin system, causing similar fetotoxic effects (fetal hypotension and renal failure). * **Thalidomide:** A notorious teratogen (Category X). It causes **Phocomelia** (seal-like limbs/flipper limbs) and internal organ malformations. It is never used in pregnancy. **High-Yield Clinical Pearls for NEET-PG:** * **Switching Rule:** PTU is used in the **1st trimester**; Methimazole is preferred in the **2nd and 3rd trimesters** to avoid PTU-induced maternal liver failure. * **Warfarin:** Contraindicated (causes Fetal Warfarin Syndrome/Chondrodysplasia punctata); **Heparin** is the anticoagulant of choice. * **Anticonvulsants:** Valproate is the most teratogenic (Neural Tube Defects); **Levetiracetam** or **Lamotrigine** are generally preferred.

Question 405: An adolescent developed metabolic acidosis after taking a certain medication. What is the causative drug?

A. Acetazolamide (Correct Answer)
B. Phenformin
C. Verapamil
D. Triamterene

Explanation: ### Explanation **Correct Option: A. Acetazolamide** Acetazolamide is a **Carbonic Anhydrase (CA) inhibitor** that acts primarily on the proximal convoluted tubule (PCT) of the kidney. It inhibits the enzyme carbonic anhydrase, preventing the reabsorption of sodium bicarbonate ($NaHCO_3$). This leads to increased urinary excretion of bicarbonate (alkaline urine), resulting in a depletion of the body's alkali reserve. The clinical consequence is a **Hyperchloremic Normal Anion Gap Metabolic Acidosis**. **Analysis of Incorrect Options:** * **B. Phenformin:** While Biguanides (like Phenformin and Metformin) are notorious for causing **Lactic Acidosis**, Phenformin has been largely withdrawn globally due to this high risk. However, in the context of standard pharmacological mechanisms involving bicarbonate loss, Acetazolamide is the classic textbook cause of metabolic acidosis. * **C. Verapamil:** This is a Calcium Channel Blocker (CCB) used for hypertension and arrhythmias. Its primary side effects include constipation, peripheral edema, and bradycardia, but it does not typically cause metabolic acidosis. * **D. Triamterene:** This is a potassium-sparing diuretic. While it can cause hyperkalemia and a mild metabolic acidosis (similar to Spironolactone), it is less commonly associated with significant systemic acidosis compared to the direct bicarbonate-wasting effect of Acetazolamide. **High-Yield Clinical Pearls for NEET-PG:** * **Acetazolamide Uses:** Glaucoma (decreases aqueous humor), Mountain Sickness (induces mild acidosis to stimulate respiration), and Urinary Alkalization. * **Side Effects:** Metabolic acidosis, hypokalemia, paresthesia, and sulfonamide-like hypersensitivity reactions. * **Acid-Base Tip:** Remember that "Proximal Renal Tubular Acidosis (Type 2 RTA)" is the physiological equivalent of Acetazolamide's mechanism of action.

Question 406: Which one of the following statements about the management of patients with gastrointestinal ulcers is accurate?

A. Histamine-2 receptor blockers are as effective as proton pump inhibitors for treating GI ulcers.
B. Antimicrobial regimens that eradicate Helicobacter pylori are more than 98% effective in treating GI ulcers.
C. Omeprazole is effective because it activates prostaglandin E1 receptors.
D. Sucralfate polymerizes in the gut, forming a protective coat over ulcer beds. (Correct Answer)

Explanation: ### Explanation **Correct Option: D. Sucralfate polymerizes in the gut, forming a protective coat over ulcer beds.** Sucralfate is a complex of aluminum hydroxide and sulfated sucrose. In an acidic environment (pH < 4), it undergoes **polymerization** to form a sticky, viscous paste. This gel-like substance has a strong affinity for exposed proteins in the ulcer base (the "crater"), creating a physical barrier against acid, pepsin, and bile. This allows the underlying tissue to heal. **Analysis of Incorrect Options:** * **Option A:** Proton Pump Inhibitors (PPIs) are significantly **more effective** than H2 blockers. PPIs provide superior acid suppression (inhibiting the final common pathway of acid secretion) and faster healing rates for both duodenal and gastric ulcers. * **Option B:** While H. pylori eradication is crucial, the success rate of standard triple or quadruple therapy is typically **80-90%** due to increasing antibiotic resistance (especially to clarithromycin). A "98%" success rate is clinically unrealistic. * **Option C:** Omeprazole is a PPI that irreversibly inhibits the **H+/K+ ATPase pump**. It has no direct action on prostaglandin receptors. **Misoprostol** is the drug that acts as a PGE1 analog. **High-Yield NEET-PG Pearls:** * **Sucralfate Administration:** It requires an acidic medium to polymerize; therefore, it should **not** be co-administered with antacids, H2 blockers, or PPIs (give it 1 hour before meals). * **Side Effects:** The most common side effect of Sucralfate is **constipation** (due to the aluminum content). * **PPI Mechanism:** PPIs are **prodrugs** activated in the acidic environment of the canaliculi of parietal cells. * **H. pylori Triple Therapy:** Includes a PPI + Amoxicillin (or Metronidazole) + Clarithromycin for 10–14 days.

Question 407: Which is a short-acting non-depolarizing neuromuscular blocker?

A. Mivacurium (Correct Answer)
B. Pancuronium
C. Succinylcholine
D. Rapacurium

Explanation: **Explanation:** Neuromuscular blockers (NMBs) are classified based on their mechanism of action (Depolarizing vs. Non-depolarizing) and their duration of action (Short, Intermediate, or Long-acting). **1. Why Mivacurium is correct:** Mivacurium is a benzylisoquinolinium derivative and is the only **short-acting non-depolarizing** NMB currently used. Its short duration (approx. 15–20 minutes) is due to its rapid metabolism by **plasma cholinesterase** (pseudocholinesterase), similar to succinylcholine. **2. Analysis of Incorrect Options:** * **Pancuronium:** This is a **long-acting** non-depolarizing NMB (duration >60 minutes). It is known for its vagolytic effect, which can cause tachycardia. * **Succinylcholine:** While it is short-acting, it is a **depolarizing** NMB. It acts as an agonist at nicotinic receptors, causing persistent depolarization. * **Rapacurium:** Although it was a rapid-onset, short-acting non-depolarizing agent, it was **withdrawn** from the market worldwide due to the high risk of severe bronchospasm. **3. High-Yield Clinical Pearls for NEET-PG:** * **Metabolism:** Most non-depolarizing drugs are metabolized by the liver or excreted by kidneys. Exceptions are **Atracurium and Cisatracurium**, which undergo **Hofmann elimination** (spontaneous degradation in plasma), making them safe in liver/kidney failure. * **Mivacurium Caution:** Since it is metabolized by plasma cholinesterase, its action is prolonged in patients with **pseudocholinesterase deficiency**. * **Histamine Release:** Mivacurium can cause histamine release, potentially leading to hypotension and flushing. * **Reversal:** Non-depolarizing blocks are reversed using Neostigmine (acetylcholinesterase inhibitor).

Question 408: In which of the following phases of a clinical trial is ethical clearance not required?

A. Phase I
B. Phase II
C. Phase III
D. Phase IV (Correct Answer)

Explanation: **Explanation:** The correct answer is **Phase IV**. This question tests the understanding of the regulatory and ethical requirements across different stages of drug development. **Why Phase IV is the correct answer:** Phase IV, also known as **Post-Marketing Surveillance**, occurs after a drug has been approved by regulatory authorities (like the FDA or CDSCO) and is available in the open market. Since the drug is already licensed for clinical use, a formal, prospective ethical clearance from an Institutional Ethics Committee (IEC) is generally **not required** for routine monitoring of adverse drug reactions (ADRs) or observational studies. However, if a Phase IV study is designed as a formal interventional trial (Phase IV RCT), ethical approval may be sought, but for the general phase of surveillance, it is the exception compared to Phases I-III [2]. **Why other options are incorrect:** * **Phase I (Human Pharmacology):** This is the first time a drug is tested in humans (usually healthy volunteers). Due to high risk and unknown safety profiles, stringent ethical clearance and informed consent are mandatory [2][3]. * **Phase II (Therapeutic Exploration):** Conducted on a small group of patients to evaluate efficacy and safety. Ethical clearance is vital to protect vulnerable patients [2][3]. * **Phase III (Therapeutic Confirmation):** Large-scale multicentric trials. These require rigorous ethical oversight to ensure the benefit-risk ratio justifies the drug's eventual marketing [2][4]. **High-Yield Clinical Pearls for NEET-PG:** * **Phase 0:** Also called **Microdosing** studies; uses sub-therapeutic doses to study pharmacokinetics. * **Phase I:** Primarily assesses **Safety** and maximum tolerated dose (MTD) [3]. * **Phase II:** Primarily assesses **Efficacy** (the "Proof of Concept" phase) [3]. * **Phase IV:** Best phase to detect **rare side effects** (e.g., Phocomelia with Thalidomide) that were not caught in smaller pre-marketing trials [1].

Question 409: What is the mechanism of action of thalidomide?

A. Antimicrobial
B. Antiemetic
C. Anti-allergic
D. Immunomodulation (Correct Answer)

Explanation: **Explanation:** Thalidomide is a complex drug originally introduced in the 1950s as a sedative, but it is now primarily classified as an **immunomodulatory imide drug (IMiD)**. **Why Immunomodulation is Correct:** Thalidomide exerts its effects through multiple pathways: 1. **TNF-α Inhibition:** It suppresses the production of Tumor Necrosis Factor-alpha (TNF-α), a potent pro-inflammatory cytokine. 2. **Cereblon Binding:** It binds to the protein **Cereblon**, part of an E3 ubiquitin ligase complex, leading to the degradation of transcription factors (like Ikaros and Aiolos) essential for B-cell and T-cell function. 3. **Anti-angiogenesis:** It inhibits the growth of new blood vessels by suppressing VEGF and bFGF. **Analysis of Incorrect Options:** * **A. Antimicrobial:** Thalidomide has no direct action against bacteria, viruses, or fungi. While used in Leprosy, it treats the *reaction* (ENL), not the *infection* (*M. leprae*). * **B. Antiemetic:** Though historically used for morning sickness (leading to the thalidomide tragedy), it is no longer indicated or classified as an antiemetic due to extreme toxicity. * **C. Anti-allergic:** It does not stabilize mast cells or block histamine receptors. **High-Yield Clinical Pearls for NEET-PG:** * **Current Indications:** 1. **Erythema Nodosum Leprosum (ENL):** Drug of choice for Type 2 Lepra reaction. 2. **Multiple Myeloma:** Used in combination with dexamethasone. * **Teratogenicity:** It is a potent human teratogen causing **Phocomelia** (seal-like limbs) if taken during the first trimester (specifically days 27–40 of gestation). * **Side Effects:** Peripheral neuropathy (most common dose-limiting toxicity) and thromboembolism.

Question 410: In metabolism, all of the following reactions are considered Phase I reactions except?

A. Oxidation
B. Reduction
C. Conjugation (Correct Answer)
D. Deamination

Explanation: Drug metabolism (biotransformation) typically occurs in two distinct phases to make lipophilic drugs more water-soluble for renal excretion [1]. **Phase I Reactions (Nonsynthetic)** These reactions involve the introduction or unmasking of a functional group (like -OH, -NH2, or -SH) [2]. They generally result in the activation, change in activity, or inactivation of a drug. The primary mechanisms include: * **Oxidation:** The most common Phase I reaction (e.g., via Cytochrome P450) [3]. * **Reduction:** Addition of hydrogen or removal of oxygen [3]. * **Hydrolysis:** Cleavage of a bond by adding water [3]. * **Cyclization and Decyclization.** * **Deamination:** Removal of an amino group (Option D) [3]. **Phase II Reactions (Synthetic)** These involve the **Conjugation** (Option C) of a drug or its Phase I metabolite with an endogenous substance (like glucuronic acid, sulfate, or glycine) [2]. These reactions almost always result in inactive, highly polar metabolites that are easily excreted [2]. **Explanation of Options:** * **Oxidation (A), Reduction (B), and Deamination (D)** are all Phase I reactions as they modify the drug molecule chemically without attaching a large endogenous molecule. * **Conjugation (C)** is the hallmark of Phase II metabolism. **High-Yield NEET-PG Pearls:** 1. **Glucuronidation** is the most common Phase II reaction. 2. **Microsomal enzymes** (located in the SER) catalyze most oxidations and glucuronidation, but **not** acetylation or sulfation (non-microsomal). 3. **Exception to the Rule:** While Phase II usually inactivates drugs, **Morphine-6-glucuronide** is a Phase II metabolite that is more potent than morphine itself.

Practice by Chapter

Pharmacokinetics: Absorption and Distribution

Practice Questions

Pharmacokinetics: Metabolism and Excretion

Practice Questions

Pharmacodynamics and Receptor Theory

Practice Questions

Drug-Receptor Interactions and Dose-Response

Practice Questions

Pharmacogenetics and Personalized Medicine

Practice Questions

Adverse Drug Reactions and Toxicity

Practice Questions

Drug Interactions

Practice Questions

Drug Development and Regulation

Practice Questions

Pediatric and Geriatric Pharmacology

Practice Questions

Placental Transfer and Lactation

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free